Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$89.9M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$71.9M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$69M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$66M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$33M |
| 2 |
Altria Group
MO
|
+$32.4M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$26.5M |
| 4 |
CVS Health
CVS
|
+$24.7M |
| 5 |
Medtronic
MDT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.23% |
| 2 | Technology | 14.6% |
| 3 | Healthcare | 11.36% |
| 4 | Industrials | 11.26% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SRGA
1426
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $84K | ﹤0.01% |
+480
| New | +$68.3K |
2017 Q2
0 quarters
|
|
|
SSI
1427
DELISTED
Stage Stores Inc
SSI
| $83K | ﹤0.01% |
+39,790
| New | +$98.2K |
2017 Q2
0 quarters
|
|
1428
Constellium
CSTM
$2.93B
| $81K | ﹤0.01% |
11,800
+300
| +3% | +$1.95K |
2016 Q4
2 quarters
|
|
|
TRQ
1429
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $81K | ﹤0.01% |
3,043
+1,829
| +151% | +$49.5K |
2017 Q1
1 quarter
|
|
1430
Goldgroup Mining
GORO
$532M
| $80K | ﹤0.01% |
4,884
-1,649
| -25% | -$25.1K |
2016 Q4
2 quarters
|
|
1431
Ameresco
AMRC
$1.15B
| $79K | ﹤0.01% |
+10,284
| New | +$69.1K |
2017 Q2
0 quarters
|
|
1432
Anavex Life Sciences
AVXL
$107M
| $77K | ﹤0.01% |
+14,400
| New | +$83.2K |
2017 Q2
0 quarters
|
|
1433
DELISTED
Mr. Cooper
COOP
| $75K | ﹤0.01% |
4,983
+786
| +19% | +$12.4K |
2016 Q4
2 quarters
|
|
|
ANH
1434
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $74K | ﹤0.01% |
12,300
-12,400
| -50% | -$73.3K |
2016 Q4
2 quarters
|
|
|
RAS
1435
DELISTED
RAIT Financial Trust
RAS
| $73K | ﹤0.01% |
33,231
+12,841
| +63% | +$33K |
2016 Q3
3 quarters
|
|
1436
SOS Limited
SOS
$3.77M
| $69K | ﹤0.01% |
+2
| New | +$105K |
2017 Q2
0 quarters
|
|
1437
FuelCell Energy
FCEL
$796M
| $68K | ﹤0.01% |
+152
| New | +$67.2K |
2017 Q2
0 quarters
|
|
1438
Oaktree Specialty Lending
OCSL
$1.1B
| $67K | ﹤0.01% |
+4,567
| New | +$58.4K |
2017 Q2
0 quarters
|
|
1439
Corbus Pharmaceuticals
CRBP
$59.4M
| $66K | ﹤0.01% |
+349
| New | +$68.4K |
2017 Q2
0 quarters
|
|
|
YUME
1440
DELISTED
YuMe, Inc.
YUME
| $66K | ﹤0.01% |
+14,041
| New | +$62K |
2017 Q2
0 quarters
|
|
|
OMED
1441
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $64K | ﹤0.01% |
+19,251
| New | +$79.9K |
2017 Q2
0 quarters
|
|
1442
Galiano Gold
GAU
$654M
| $61K | ﹤0.01% |
40,136
-43,170
| -52% | -$89K |
2017 Q1
1 quarter
|
|
1443
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $61K | ﹤0.01% |
+686
| New | +$49.3K |
2017 Q2
0 quarters
|
|
1444
Valhi
VHI
$456M
| $60K | ﹤0.01% |
+1,675
| New | +$66.6K |
2017 Q2
0 quarters
|
|
1445
DELISTED
Independence Contract Drilling, Inc.
ICD
| $60K | ﹤0.01% |
770
-378
| -33% | -$33K |
2016 Q4
2 quarters
|
|
1446
DELISTED
MANNING & NAPIER, INC.
MN
| $60K | ﹤0.01% |
+13,855
| New | +$68.8K |
2017 Q2
0 quarters
|
|
|
MR
1447
DELISTED
Montage Resources Corporation Common Stock
MR
| $60K | ﹤0.01% |
1,407
-1,581
| -53% | -$55.3K |
2016 Q3
3 quarters
|
|
1448
Tidewater
TDW
$3.49B
| $59K | ﹤0.01% |
+2,545
| New | +$68.4K |
2017 Q2
0 quarters
|
|
1449
DELISTED
Nobilis Health Corp.
HLTH
| $59K | ﹤0.01% |
+31,308
| New | +$47.4K |
2017 Q2
0 quarters
|
|
1450
Gerdau
GGB
$8.59B
| $58K | ﹤0.01% |
+23,929
| New | +$56.5K |
2017 Q2
0 quarters
|
|
Similar funds
Squarepoint's Q2 2017 Portfolio in Review
As of Q2 2017, Squarepoint held 2,064 positions worth $5.08B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Squarepoint deployed $1.39B of net new capital in Q2 2017, opening 586 new positions and adding to 519 existing holdings. Its largest new stake was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $33M trimmed.
- Squarepoint's largest Q2 2017 buy was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
- Squarepoint added most to VanEck Gold Miners ETF in Q2 2017, an estimated $71.9M increase.
- Squarepoint's biggest Q2 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $33M.
- Squarepoint fully exited iShares MSCI EAFE ETF in Q2 2017, selling an estimated $26.5M.
- Squarepoint's ten largest holdings make up 16% of its $5.08B portfolio in Q2 2017.
- Squarepoint opened 586 new positions and closed 568 in Q2 2017.
- Squarepoint's portfolio value rose 40% quarter-over-quarter to $5.08B.
Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.